Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Issuance of Common Stock

Arena Pharmaceuticals Issuance of Common Stock Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Issuance of Common Stock from 2000 to 2018.
  • Arena Pharmaceuticals Issuance of Common Stock for the quarter ending September 09, 2018 was $1m a -11,249.18% decrease of -165m year over year
  • Arena Pharmaceuticals Issuance of Common Stock for the last 12 months ending September 09, 2018 was $389m a 36.03% increase of 140m year over year
  • Arena Pharmaceuticals Annual Issuance of Common Stock for 2017 was $249m a 99.85% increase of 248m from 2016
  • Arena Pharmaceuticals Annual Issuance of Common Stock for 2016 was $0m a -27,907.57% decrease of -103m from 2015
  • Arena Pharmaceuticals Annual Issuance of Common Stock for 2015 was $104m a 94.96% increase of 98m from 2014
Other Cash Flow Metrics:
  • Arena Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-31m a 40.98% decrease of -13m year over year
  • Arena Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-18m a 99.28% decrease of -18m year over year
  • Arena Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $4m a -330.00% decrease of -12m year over year
View Chart On Koyfin

Quarterly ARNA Issuance of Common Stock Data

09/2018$1m
06/2018$2m
03/2018$385m
09/2017$167m
06/2017$76m
03/2017$5m
09/2016$0m
06/2016$0m
03/2016$0m
12/2015$1m

Annual ARNA Issuance of Common Stock Data

2017$249m
2016$0m
2015$104m
2014$5m
2013$3m
2012$151m
2011$18m
2010$120m
2009$65m
2008$2m